Seeking Alpha

Pharma Reports

ABOUT
"Prediction is very difficult, especially if it's about the future." Nils Bohr

Leading pharmaceutical companies invest billions of dollars each year in research and development with little or no guarantee of a return on their investment.

With the average cost of developing a new drug hitting the $800 million mark, accurately forecasting the market potential for new compounds is becoming an essential tool in long-term strategic planning.

Forecasting is also essential in understanding how the dynamics of a market are changing, evaluating licensing and acquisition opportunities for a particular therapeutic candidate, and raising the awareness of company executives of both current and ...More

See Seeking Alpha's policy on anonymous authors.

SNAPSHOT
  • Description: Independent / boutique research firm analyst.
  • Interests: Stocks - long
COMPANY
Currently, you have no company profile. Click edit to add a company profile.
BLOG
Currently, you have no blog details. Click edit to add blog details.
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Gilead Sciences: Will It Double Your Money Again In 2014? $GILD http://seekingalpha.com/a/161fn Jan 23, 2014